Lilly invests additional $4.5 billion in LEAP

Eli Lilly and Co. CEO Dave Ricks called this week’s announcement a unique moment for the pharmaceutical industry. Lilly is investing $4.5 billion to create the Medicine Foundry, a first of its kind center combining research and advanced manufacturing in a single location. It will focus on new ways of producing medicines and fueling Lilly’s growing pipeline.

Biocrossroads CEO Vince Wong joins Gerry Dick to talk about the impact of this investment and the growing life sciences industry in Indiana.